In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI–MS spectrumLuis Ariel Espinosa, Luis Javier González, A.M. Martin et al.|Analytical and Bioanalytical Chemistry|2021Cited by 17
HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure ProphylaxisVerena Muzio, Jorge Aguiar, Gerardo García et al.|Euroasian Journal of Hepato-Gastroenterology|2021Cited by 12
In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrumLuis Ariel Espinosa, Luis Javier González, Yassel Ramos et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 4